VIVS - VivoSim Labs, Inc. News

VivoSim Labs Announces First Commercial Sales In China For Its NAMkind Testing Services

, Inc. (NASDAQ:VIVS) (the "Company" or "VivoSim"), a provider of next-generation New

VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testi

Initial customer wins bring VivoSim's human-relevant liver and GI testing to the world's second-larg

Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partner

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's

Why Is VivoSim Labs Stock Falling Thursday?

VivoSim Labs (VIVS) stock plunges over 25% on a $4M private placement priced at $0.85/share. Read ab

VivoSim Labs Prices ~$4M Private Placement Of Common Stock, Pre-Funded Warrants At Combined Price Of

VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-g

VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "Vi

Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday&#3

Why Vivosim Labs Shares Are Rocketing on Wednesday?

VivoSim Labs shares climbed after receiving a $5 million Eli Lilly milestone payment and forecasting

VivoSim Labs Anticipates 500% Revenue Growth In FY27; Receives $5M Milestone Payment From Eli Lilly

VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-g

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Gro

SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “Vi

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's

VivoSim Labs To Present Data Demonstrating Its 3D Human Tissue Models In Two Presentations At The Eu

The presentations collectively showcase the best-in-industry predictive power of VivoSim's propr

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Tox

SAN DIEGO, June 29, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "Vi

VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intes

VivoSim's NAMkind™ Intestinal Model combined with AI prediction tools yields high-accuracy results V

Short Interest in VivoSim Labs, Inc. (NASDAQ:VIVS) Decreases By 69.3%

VivoSim Labs, Inc. (NASDAQ: VIVS - Get Free Report) was the target of a large decline in short inter

12 Health Care Stocks Moving In Friday's After-Market Session

VivoSim Announces Pricing of up to a $4 Million Public Offering

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS), (the “Company” or “

Head-To-Head Analysis: Agenus (NASDAQ:AGEN) and VivoSim Labs (NASDAQ:VIVS)

VivoSim Labs (NASDAQ: VIVS - Get Free Report) and Agenus (NASDAQ: AGEN - Get Free Report) are both s

VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide D

ADCs are a major new market; Company demonstrates ability to discern antibody toxicity from payload

VivoSim Labs, Inc. (NASDAQ:VIVS) Short Interest Update

VivoSim Labs, Inc. (NASDAQ: VIVS - Get Free Report) saw a significant drop in short interest in the

VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales

Veteran business development leader with deep expertise in human-relevant NAM and spheroid-based in

VivoSim Labs, Inc. (NASDAQ:VIVS) Sees Significant Decline in Short Interest

VivoSim Labs, Inc. (NASDAQ: VIVS - Get Free Report) was the recipient of a large decrease in short i

12 Health Care Stocks Moving In Friday's After-Market Session

VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, a

Company produces thorough reference testing on Antibody Drug Conjugates, showing high correlation wi

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distribu

SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “Vi

Analyzing Bristol Myers Squibb (NYSE:BMY) & VivoSim Labs (NASDAQ:VIVS)

VivoSim Labs (NASDAQ: VIVS - Get Free Report) and Bristol Myers Squibb (NYSE: BMY - Get Free Report)

VivoSim Labs (NASDAQ:VIVS) and MediciNova (NASDAQ:MNOV) Head-To-Head Analysis

MediciNova (NASDAQ: MNOV - Get Free Report) and VivoSim Labs (NASDAQ: VIVS - Get Free Report) are bo

VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer

Distinguished drug-development and biomarker leader to advance NAMkind™ scientific strategy, transla

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session